S. Zhang

Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer

Fei Liang, S. Zhang, Q. Wang et al. · Annals of Oncology · 2018 · 60 citations

Role of industry funders in oncology RCTs published in high-impact journals and its association with trial conclusions and time to publication

Fei Liang, Jun Zhu, M. Mo et al. · Annals of Oncology · 2018 · 49 citations · Full text

Intra-abdominal fibromatosis: Differentiation from gastrointestinal stromal tumour based on biphasic contrast-enhanced CT findings

Hui Zhu, Hongliang Chen, S. Zhang et al. · Clinical Radiology · 2013 · 37 citations

Intra-abdominal Fibromatosis, Medical Imaging, Biliary Cancer +10

P2Y12 protects platelets from apoptosis via PI3k‐dependent Bak/Bax inactivation

S. Zhang, J. YE, Y. Zhang et al. · Journal of Thrombosis and Haemostasis · 2012 · 33 citations · Full text

Pi3k‐dependent Bak/bax Inactivation, Thrombosis, Platelet Aggregation Inhibitors +8

Tumor vascular disrupting agent 5,6‐dimethylxanthenone‐4‐acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase

S.H. ZHANG, Y. Zhang, Jian Shen et al. · Journal of Thrombosis and Haemostasis · 2013 · 27 citations · Full text

Acid Inhibits, Thrombosis, Blood Platelet +10